Ozempic 2 MG/dose (8 MG/3 ML) 3ML
Ended Awarded Last action
- Contract number
- SPE2DR26FC7KF
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,152
Award facts
- Contract value 100% obligated
- $10,152.45 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $10,152.45 to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 ml) in 3 ml vials. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of January 29, 2026, and was awarded on January 28, 2026. The place of performance is located in Conshohocken, Pennsylvania, which serves as the vendor's corporate headquarters. No set-aside designation was applied to this award, indicating it was competitively awarded on a full and open basis.
This delivery order represents a task order issued under AmerisourceBergen Drug Corp's significant Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026. The parent company, Cencora, Inc. (doing business as AmerisourceBergen), holds a corresponding prime IDC with DLA valued at up to $999,999,999.00 through December 31, 2031, which serves as the primary vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally. Ozempic, a diabetes medication, aligns with the comprehensive pharmaceutical portfolio that AmerisourceBergen supplies across multiple therapeutic domains to military treatment facilities and federal healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FC7KF?
SPE2DR26FC7KF was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26FC7KF worth?
The government has obligated $10,152 on SPE2DR26FC7KF.
Is contract SPE2DR26FC7KF an order under another contract?
Yes. SPE2DR26FC7KF is a delivery order under SPE2DR25D2217, an indefinite delivery contract.
Was contract SPE2DR26FC7KF competed?
The extent of competition for SPE2DR26FC7KF was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award